FDA Application
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Application

  • Print
  • Share
  • E-mail

Orapred (Prednisolone Sodium Phosphate) Oral Solution
Company:  Ascent Pediatrics
Application No.:  75-117
Approval Date: 12/14/2000



Date created: November 20, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.